<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.phyplu.2021.100204"><dct:format>application/xml</dct:format><dct:title>The total flavonoids of Hippophae rhamnoides stimulate recruitment of CD8+ T cells into the tumor microenvironment promoting cancer immune control</dct:title><dct:creator>Yuanyuan Hao</dct:creator><dct:creator>Yue Xiao</dct:creator><dct:creator>Jiangna Yan</dct:creator><dct:creator>Ruijie Yang</dct:creator><dct:creator>Ruifei Huang</dct:creator><dct:creator>Chunli Zheng</dct:creator><dct:creator>Chao Huang</dct:creator><dct:creator>Xuetong Chen</dct:creator><dct:creator>Wei Xiao</dct:creator><dct:creator>Jie Lei</dct:creator><dct:creator>Jianling Liu</dct:creator><dct:subject><rdf:Bag><rdf:li>Non-small cell lung cancer</rdf:li><rdf:li>Chronic inflammatory factors</rdf:li><rdf:li>Antitumor immunotherapy</rdf:li><rdf:li>Systems pharmacology</rdf:li></rdf:Bag></dct:subject><dct:description>Phytomedicine Plus 2 (2022). doi:10.1016/j.phyplu.2021.100204</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Phytomedicine Plus</prism:publicationName><prism:copyright>&#169; 2021 The Authors. Published by Elsevier B.V.</prism:copyright><dct:publisher>Elsevier B.V.</dct:publisher><prism:issn>2667-0313</prism:issn><prism:volume>2</prism:volume><prism:number>1</prism:number><prism:coverDisplayDate>February 2022</prism:coverDisplayDate><prism:doi>10.1016/j.phyplu.2021.100204</prism:doi><prism:url>http://dx.doi.org/10.1016/j.phyplu.2021.100204</prism:url><dct:identifier>doi:10.1016/j.phyplu.2021.100204</dct:identifier><bam:articleNumber>100204</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-12-16T16:02:03Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.1</dp:version-number></dp:document-properties><ja:article docsubtype="fla" version="5.6" xml:lang="en"><ja:item-info><ja:jid>PHYPLU</ja:jid><ja:aid>100204</ja:aid><ce:article-number>100204</ce:article-number><ce:pii>S2667-0313(21)00186-X</ce:pii><ce:doi>10.1016/j.phyplu.2021.100204</ce:doi><ce:copyright type="unknown" year="2021"/></ja:item-info><ja:head><ce:title id="tte0002">The total flavonoids of Hippophae rhamnoides stimulate recruitment of CD8+ T cells into the tumor microenvironment promoting cancer immune control</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S266703132100186X-b204029f74f28cd8362701a7dd7943e6"><ce:given-name>Yuanyuan</ce:given-name><ce:surname>Hao</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0002" author-id="S266703132100186X-7741a0938d466753d55f907dfd9e24cd"><ce:given-name>Yue</ce:given-name><ce:surname>Xiao</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0003" author-id="S266703132100186X-960e37126666c0074b5b0f008583c8a7"><ce:given-name>Jiangna</ce:given-name><ce:surname>Yan</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0004" author-id="S266703132100186X-160b799c903070493d9bd8d87285df1a"><ce:given-name>Ruijie</ce:given-name><ce:surname>Yang</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0005" author-id="S266703132100186X-bd4951c1e1858bd676f662751f40cc64"><ce:given-name>Ruifei</ce:given-name><ce:surname>Huang</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0006" author-id="S266703132100186X-fc6851c5f55b99838c0f3f394b0bdd26"><ce:given-name>Chunli</ce:given-name><ce:surname>Zheng</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref></ce:author><ce:author id="au0007" author-id="S266703132100186X-4841f80a7e028c5bc9c9009314d0380e"><ce:given-name>Chao</ce:given-name><ce:surname>Huang</ce:surname><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0008" author-id="S266703132100186X-bf96077b29b98309f31c91e0b2248bad"><ce:given-name>Xuetong</ce:given-name><ce:surname>Chen</ce:surname><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0009" author-id="S266703132100186X-51a72bb2f790a98a7a4a26415baa1745"><ce:given-name>Wei</ce:given-name><ce:surname>Xiao</ce:surname><ce:cross-ref refid="aff0004"><ce:sup loc="post">d</ce:sup></ce:cross-ref><ce:e-address id="ead0001b" type="email" xlink:href="mailto:xw_kanion@163.com">xw_kanion@163.com</ce:e-address></ce:author><ce:author id="au0010" author-id="S266703132100186X-70fe6b3429dd03e331711da7646e93f9"><ce:given-name>Jie</ce:given-name><ce:surname>Lei</ce:surname><ce:cross-ref refid="aff0003"><ce:sup loc="post">c</ce:sup></ce:cross-ref><ce:e-address id="ead0001a" type="email" xlink:href="mailto:leijiemd@163.com">leijiemd@163.com</ce:e-address></ce:author><ce:author id="au0011" author-id="S266703132100186X-9c55e7acce961b396186818e9b6f4126"><ce:given-name>Jianling</ce:given-name><ce:surname>Liu</ce:surname><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:Liujl@nwu.edu.cn">Liujl@nwu.edu.cn</ce:e-address></ce:author><ce:affiliation id="aff0001" affiliation-id="S266703132100186X-94632b7ba0e4163d0a49ce27379bbba5"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an, China</ce:textfn><sa:affiliation><sa:organization>Key Laboratory of Resource Biology and Biotechnology in Western China</sa:organization><sa:organization>Ministry of Education, School of Life Sciences, Northwest University</sa:organization><sa:city>Xi'an</sa:city><sa:country>China</sa:country></sa:affiliation><ce:source-text id="staff0001">aKey Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an, China</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S266703132100186X-4f49b3d3ea1b8e85db16dfdee808ab31"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">Lab of Systems Pharmacology, Center of Bioinformatics, College of Life Science, Northwest A&amp;F University, Yangling, China</ce:textfn><sa:affiliation><sa:organization>Lab of Systems Pharmacology, Center of Bioinformatics</sa:organization><sa:organization>College of Life Science, Northwest A&amp;F University</sa:organization><sa:city>Yangling</sa:city><sa:country>China</sa:country></sa:affiliation><ce:source-text id="staff0002">bLab of Systems Pharmacology, Center of Bioinformatics, College of Life Science, Northwest A&amp;F University, Yangling, China</ce:source-text></ce:affiliation><ce:affiliation id="aff0003" affiliation-id="S266703132100186X-8994dc1dc610d47436f7901e36a83ea5"><ce:label>c</ce:label><ce:textfn id="cetextfn0003">Department of Thoracic Surgery, Tangdu Hospital, the Forth Military Medical University, Xi'an, China</ce:textfn><sa:affiliation><sa:organization>Department of Thoracic Surgery</sa:organization><sa:organization>Tangdu Hospital, the Forth Military Medical University</sa:organization><sa:city>Xi'an</sa:city><sa:country>China</sa:country></sa:affiliation><ce:source-text id="staff0003">cDepartment of Thoracic Surgery, Tangdu Hospital, the Forth Military Medical University, Xi'an, China</ce:source-text></ce:affiliation><ce:affiliation id="aff0004" affiliation-id="S266703132100186X-14e289770e6a432848b6b492ff17538b"><ce:label>d</ce:label><ce:textfn id="cetextfn0004">State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Parmaceutical, Co., Ltd., Lianyungang, China</ce:textfn><sa:affiliation><sa:organization>State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process</sa:organization><sa:organization>Jiangsu Kanion Parmaceutical, Co., Ltd.</sa:organization><sa:city>Lianyungang</sa:city><sa:country>China</sa:country></sa:affiliation><ce:source-text id="staff0004">dState Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Parmaceutical, Co., Ltd., Lianyungang, China</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding author.</ce:text></ce:correspondence></ce:author-group><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" role="background" view="all"><ce:section-title id="cesectitle0002">Background</ce:section-title><ce:simple-para id="spara006" view="all">: Despite the immune checkpoint blocking therapy has changed the treatment of many cancers, most patients do not respond due to enhanced immunosuppression in the tumor microenvironment (TME). <ce:italic>Hippophae rhamnoides</ce:italic> Linn. (HR) is a widely concerned Edible Traditional Chinese medicine, it has been proved to have a certain immune-regulatory effect.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0002" view="all"><ce:section-title id="cesectitle0003">Purpose</ce:section-title><ce:simple-para id="spara007" view="all">: In this study, we attempt to explore whether HR will provide a unique opportunity for immunotherapy.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0003" role="materials-methods" view="all"><ce:section-title id="cesectitle0004">Method</ce:section-title><ce:simple-para id="spara008" view="all">: A systems pharmacology and RNA-seq analysis was used to reveal the potential mechanism of anti-tumor of HR. And we also used Western blot, real-time PCR, Flowcytometric analysis and other experimental techniques to verify the relevant mechanisms. Finally, the effects of combination regimens were examined in a non-small cell lung cancer (NSCLC) preclinical model.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0004" role="results" view="all"><ce:section-title id="cesectitle0005">Results</ce:section-title><ce:simple-para id="spara009" view="all">: We demonstrate that the total flavonoids of HR (TFH) is the key for HR to play an anti-cancer role. TFH therapy activates the chemokine signaling pathway by downregulating the expression of chronic inflammatory factors, which results in increased CD8<ce:sup loc="post">+</ce:sup><ce:italic>T</ce:italic> cells recruitment to the TME. In line with this, TFH enhanced the expression of related chemokines CCL5, XCL1, CXCL9/10, and induces a significant down-regulation of the negative regulatory factor prostaglandin E2 (PGE2). Ultimately, preclinical data suggest that TFH treatment in combination with anti-PD-1 blockade in inducing eradication of tumors.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0005" role="conclusion" view="all"><ce:section-title id="cesectitle0006">Conclusion</ce:section-title><ce:simple-para id="spara010" view="all">: TFH could be used as an effective adjuvant for immunotherapy of tumor patients.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract id="abs0002" class="graphical" view="all"><ce:section-title id="cesectitle0007">Graphical abstract</ce:section-title><ce:abstract-sec id="abss0007" view="all"><ce:simple-para id="spara011" view="all"> [Display omitted] </ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0008">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Non-small cell lung cancer</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Chronic inflammatory factors</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Antitumor immunotherapy</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Systems pharmacology</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
